Cardiovascular risk: its assessment in clinical practice

被引:0
|
作者
Wilson, SL
Poulter, NR
机构
[1] Barts & London Hosp, William Harvey Res Inst, London EC1M 6BQ, England
[2] Imperial Coll Sch Med, Dept Clin Pharmacol, Cardiovasc Studies Unit, London W2 1PG, England
关键词
cardiovascular system; Framingham equation; risk assessment; risk factors;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Cardiovascular disease is one of the major causes of mortality and morbidity in Western industrialised countries. Many factors impact on the likelihood of an individual suffering a stroke or heart attack. One of the greatest challenges facing clinicians today is how best to identify those individuals at increased risk, to prevent them becoming tomorrow's patients. Risk assessment tools can provide useful frameworks to support the identification of individuals who may benefit from therapeutic intervention: however, such tools should be used with care, as they do not include all the factors that contribute to future disease risk, and they are subject to an age bias. Nonetheless, they provide a systematic, evidence-based approach to the delivery of preventative healthcare services.
引用
收藏
页码:248 / 251
页数:4
相关论文
共 50 条
  • [21] Cardiovascular risk management in clinical practice: Time to change
    Volpe M.
    Erhardt L.R.W.
    Williams B.
    High Blood Pressure & Cardiovascular Prevention, 2008, 15 (1) : 9 - 16
  • [22] The metabolic syndrome and cardiovascular risk: implications for clinical practice
    Eddy, D. M.
    Schlessinger, L.
    Heikes, K.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (Suppl 2) : S5 - S10
  • [23] The metabolic syndrome and cardiovascular risk: implications for clinical practice
    D M Eddy
    L Schlessinger
    K Heikes
    International Journal of Obesity, 2008, 32 : S5 - S10
  • [24] Cardiovascular Disease Risk Prediction - Integration into Clinical Practice
    Abd T.T.
    Blaha M.J.
    Blumenthal R.S.
    Joshi P.H.
    Current Cardiovascular Risk Reports, 2013, 7 (5) : 346 - 353
  • [25] Clinical practice guideline for cardiovascular risk management in the Netherlands
    Smulders, Y. M.
    Burgers, J. S.
    Scheltens, T.
    van Hout, B. A.
    Wiersma, T.
    Simoons, M. L.
    NETHERLANDS JOURNAL OF MEDICINE, 2008, 66 (04): : 169 - 174
  • [26] RHEUMATIC DISEASES AND CARDIOVASCULAR RISK: IMPLICATIONS FOR CLINICAL PRACTICE
    Nurmohamed, M. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 29 - 29
  • [27] CLINICAL PRACTICE GIDELINE: Suicide Risk Assessment
    Zaleski, Mary Ellen
    Johnson, Mindi L.
    Valdez, Anna Maria
    Bradford, Judith Young
    Reeve, Nancy Erin
    Horigan, Annie
    Killian, Marylou
    Reeve, N. Erin
    Slivinski, Andrea
    Stapleton, Stephen
    Vanhoy, Mary Alice
    Proehl, Jean
    Wolf, Lisa
    Delao, Altair
    Gates, Leslie
    JOURNAL OF EMERGENCY NURSING, 2018, 44 (05)
  • [28] Osteoporotic fractures:: risk assessment in clinical practice
    Vazquez Diaz, Monica
    Garcia Franco, Alberto Lopez
    Isasi Zaragoza, Carlos
    Aguado Acin, Pilar
    MEDICINA CLINICA, 2007, 129 (11): : 418 - 423
  • [29] Comparison of cardiovascular risk assessment and LDL cholesterol target values:: Various guidelines versus clinical practice
    Malek, F.
    Gao, M.
    Frohlich, J. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 103 - 103
  • [30] The use of cardiac specific biomarkers for cardiovascular risk assessment in asymptomatic individuals: is it a valuable approach in clinical practice?
    Rubattu, Speranza
    INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2021, 10